Introduction {#s0001}
============

Diabetes mellitus is a global health concern with 415 million affected people in 2015. Approximately 75% of diabetic patients live in low and middle income countries and most affected people are in the productive years of their lives (International Diabetes Federation [@CIT0015]). The disease causes premature illness and death due to complications, mainly through the increased risk of cardiovascular diseases. Diabetes has also become a leading cause of blindness, non-traumatic amputation and renal failure. These complications account for much of the social and financial burden of diabetes (World Health Organization and International Diabetes Federation [@CIT0044]). In 2015, five million people died from the complications associated with this disease (IDF [@CIT0015]).

Primary target of management of diabetes is to lower the blood glucose concentration, as hyperglycaemia is the clinical hallmark of diabetes (Sheard et al. [@CIT0038]). Mechanisms reducing blood glucose concentration include lowering of the postprandial blood glucose elevation. Pancreatic α-amylase catalyzes the initial step of starch hydrolysis by breaking the α-1,4-glycosidic link yielding a mixture of maltose and a number of small oligosaccharides (Sales et al. [@CIT0032]). α-Glucosidases present in the intestinal brush border release glucose by hydrolyzing the maltose and oligosaccharides (Kumar et al. [@CIT0023]). Inhibitors of pancreatic α-amylase and α-glucosidase are known to serve as important strategies in the management of blood glucose concentration in diabetic patients as they cause a reduction in the postprandial increase in serum glucose concentration (Alagesan et al. [@CIT0001]).

Despite the availability of antidiabetic drugs, diabetes and the related complications continue to be a major medical problem. Many of these oral antidiabetic agents have a number of serious adverse effects, thus managing diabetes without side effects is still a challenge. Therefore, the search for more effective and safer drugs continues as an important area of investigation. Currently, there is more interest in plant-based remedies as an affordable and safer mode of therapy in controlling diabetes mellitus. Studies of traditional remedies used around the world have identified more than 1200 species of plants with hypoglycaemic activity (Grover et al. [@CIT0013]) as a hidden wealth of potentially useful natural products for diabetes control. Although many of these remedies are known to be effective for thousands of years, only few have been scientifically validated and investigated for the bioactive compounds despite of the recommendations of World Health Organization (WHO) for further investigation. Natural products with antidiabetic potential isolated from medicinal plants were reported as saponins, flavonoids, alkaloids, anthraquinones, terpenoids, coumarins, phenolics and some polysaccharides (Qi et al. [@CIT0029]). Only a few studies have been reported on the isolation of α-amylase inhibitors from plants (Ali et al. [@CIT0003]; Karthic et al. [@CIT0018]).

*Syzygium cumini* (L.) Skeels (Myrtaceae) (SC) is a large evergreen tropical tree, widely distributed from historical times in the South Asian countries such as Sri Lanka, India, Bangladesh, Nepal and Pakistan (Ayyanar & Subash-Babu [@CIT0004]). SC (local name: *Madan*) is also known as *Eugenia jambalaya* Lam.*, Myrtus cumini* L., *Syzygium jambolanum* DC. and *Eugenia cumini* (L.) Druce (Ayyanar & Subash-Babu [@CIT0004]). Widespread use of almost all the parts of SC in traditional medicine reflects its pharmacological value against many diseases. SC is one of the medicinal plants that are recognized as most effective in the treatment of diabetes (Jung et al. [@CIT0016]). There are some studies validating the effectiveness of the bark and seed of SC (see discussion section). However, only limited data are available on the SC leaves even though it is a plant source widely available throughout the year.

The objective of this study was to isolate α-amylase inhibitors from SC leaves using bioassay-guided fractionation and to identify the active compounds.

Materials and methods {#s0002}
=====================

General materials {#s0003}
-----------------

^1^H and ^13^C NMR spectra were recorded with a Bruker DRX-500 spectrometer (500 and 125 MHz for ^1^H and ^13^C) in CDCl~3~ containing a drop of CD~3~OD. ^1^H chemical shifts are expressed in reference to the internal standard tetramethylsilane (δ 0.00), while ^13^C chemical shifts are referenced to CDCl~3~ solvent (*δ* 77.0). Column chromatography was carried out on silica gel \[Merck Art 7734 (70--230 mesh) and 9385 (230--400 mesh)\]. Thin-layer chromatography (TLC) and preparative TLC (PTLC) were conducted on aluminium sheets pre-coated with silica gel (Merck 1.05554.0007, 60F~254~). HPLC was performed on a Shimadzu LC-6A chromatograph with a UV detector. Ursolic acid and oleanolic acid hydrate were purchased from Tokyo Chemical Industry Co., Ltd. and the latter was used for the assay without further drying. Porcine pancreatic α-amylase, *p*-nitrophenyl α-[d]{.smallcaps}-glucopyranoside, α-glucosidase, acarbose and other general reagents were from Sigma.

Plant material {#s0004}
--------------

*Syzygium cumini* leaves were collected from Jaffna District, Sri Lanka in October 2013 and March 2014. Isolation was conducted with the latter. Plant was authenticated by Dr A.M.A.S. Attanayake, Deputy Director, National Herbarium, Royal Botanical Gardens and the voucher specimen (HKIP-JKP-BIO-2013-01) was deposited at the Royal Botanical Gardens, Peradeniya, Sri Lanka. Duration of the study was from October 2013 to October 2015.

Extraction of SC leaves {#s0005}
-----------------------

SC leaves were cleaned and dried under shade for one week. Dried leaves were ground to a powder using a grinder. The leaf powder (1.00 kg) was sequentially extracted with hexane, ethyl acetate, methanol and water (each solvent 2 L × 3). Respective solvents were filtered and evaporated using a rotary evaporator at 45--50 °C to give 25, 47.5, 172 and 95 g of dry extracts. Another batch of the leaf powder (278 g) was directly extracted with ethyl acetate in a similar manner to give 25 g of dry extract. The dried extracts were stored in a refrigerator until use for the inhibitory assays. Parts of the dried extracts were re-suspended in deionized water to the required concentrations for the assays. DMSO was used to solubilize the extracts, if necessary.

Chromatographic fractionation of ethyl acetate extract {#s0006}
------------------------------------------------------

Ethyl acetate dry extract (25 g) obtained directly from SC leaf powder was subjected to column chromatography over silica gel (70--230 mesh) with gradient elutions of hexane:ethyl acetate followed by ethyl acetate:methanol. Fractions were collected at uniform intervals and the progress of separation was monitored by TLC. Compounds were visualized by employing a UV lamp (254 and 360 nm) and using *p*-anisaldehyde reagent. Column fractions were combined based on the TLC pattern and the solvents were evaporated using a rotary evaporator. Combined fractions were analyzed for α-amylase inhibitory activity, which indicated the fraction eluted from 1:1 to 0:1 hexane:ethyl acetate was found to be most active. The active fraction was chromatographed again over silica gel (70--230 mesh) with gradient elutions of hexane:dichloromethane followed by dichloromethane:methanol. Fraction collected from 1:3 hexane:dichloromethane to 19:1 dichloromethane:methanol was found to be most active. This active fraction was further chromatographed over silica gel (230--400 mesh) with gradient elutions of hexane:dichloromethane followed by dichloromethane-methanol. The fraction eluted with dichloromethane:methanol (19:1 to 17:3) was further purified by PTLC (developed with 3% methanol:chloroform in a chamber saturated with NH~3~) to give the active fraction (28 mg) as a white solid.

Structure elucidation {#s0007}
---------------------

Active compound was identified by detailed analysis of ^1^H NMR and ^13^C NMR spectroscopic data and the direct comparison with TLC.

Measurement of α-amylase inhibitory effects {#s0008}
-------------------------------------------

Percentage α-amylase inhibitions of the test samples were determined according to the published method (Geethalakshmi et al. [@CIT0011]). Briefly, porcine pancreatic α-amylase was dissolved in ice-cold distilled water (5 unit/mL solution). Potato starch (1% w/v) in 20 mM phosphate buffer (pH 6.9) containing 6.7 mM sodium chloride was used as the substrate solution. Plant extract or the fraction (40 μL) was mixed with 80 μL of 20 mM phosphate-buffered saline (pH 6.9) and with 40 μL α-amylase. Eppendorf tubes with the reaction mixtures were pre-incubated for 15 min at 37 °C and then 1% potato starch (40 μL) was added to the tubes. Final concentrations used for the extract or the fraction included 20--1000 μg/mL. Final concentrations used for ursolic acid and oleanolic acid were 2--50 μg/mL and 20--80 μg/mL, respectively. Control was carried out in the absence of plant extract or standard inhibitor. Test blanks were conducted in the presence of plant extracts without α-amylase. A blank reaction was carried out with 40 μL of the respective solvent replacing the plant extract. Acarbose (Sigma) was used as the standard inhibitor. Reaction mixtures were incubated for 3 min at 37 °C. Dinitrosalicylic acid colour reagent (96 mM 3,5-dinitrosalicylic acid, 5.31 M sodium potassium tartarate in 2 M NaOH) was added (100 μL) to all the tubes and kept immediately in a water bath at 85 °C for 15 min. Distilled water (900 μL) was added to each tube and the absorbance was measured at 540 nm.

Measurement of α-glucosidase inhibitory effects {#s0009}
-----------------------------------------------

Inhibitory effects of the fraction isolated from PTLC (pure fraction), UA and OA against α-glucosidase were determined using the published method (Elya et al. [@CIT0010]). Briefly, 200 μL of 67 mM sodium phosphate buffer (pH 6.8) and 120 μL of 10 mM *p*-nitrophenyl α-[D]{.smallcaps}-glucopyranoside (Sigma) were added to the Eppendorf tubes. Isolated pure fraction (40 μL) containing final concentration of 10--60 μg/mL was added to the test and test blank. Final concentrations used for ursolic acid and oleanolic acid were 2--32 μg/mL and 20--80 μg/mL, respectively. Mixtures were pre-incubated for 15 min at 37 °C. Thereafter, 40 μL of α-glucosidase (0.1 U) from *Saccharomyces cerevisiae* (Sigma) was added to the tests and control. Reaction mixtures were incubated for 15 min at 37 °C and terminated by adding 200 mM sodium carbonate (800 μL). The hydrolysis of α-[d]{.smallcaps}-glucopyranoside to *p*-nitrophenol was measured at 405 nm.

Calculation of percentage inhibition of enzyme activities and IC~50~ {#s0010}
--------------------------------------------------------------------

Percentage inhibition was calculated using the following formula (Olaokun et al. [@CIT0027]). $${Percentage}\quad{inhibition} = 100 - \frac{\left( {Absorbance}\quad{of}\quad{test} - {Absorbance}\quad{of}\quad{test}\quad{blank} \right)}{\left( {Absorbance}\quad{of}\quad{control} - {Absorbance}\quad{of}\quad{control}\quad{blank} \right)} \times 100$$

The concentration of the extract or the fraction or the compound that inhibits 50% of the enzyme activity (IC~50~) was calculated using a series of suitable concentrations. IC~50~ values were determined by plotting per cent inhibition (*Y* axis) versus log~10~ extract concentration (*X* axis) and calculated by logarithmic regression analysis from the mean inhibitory values (Sudha et al. [@CIT0040]).

Statistical analysis {#s0011}
--------------------

Enzyme inhibitory assays were carried out on three separate occasions. Each measurement was taken in triplicates. Data are expressed as mean ± standard deviation. Statistical analysis was performed using ANOVA to compare the means of different fractions. Values of *p* \< 0.05 were considered as significantly different.

Results {#s0012}
=======

Each extract of dried leaves of the *S. cumini* was subjected to porcine pancreatic α-amylase inhibitory bioassay. Methanol and water extracts showed the highest α-amylase inhibitory activity (98.3 ± 2.3 and 98.6 ± 1.6%, respectively, with 1 mg/mL extracts). Ethyl acetate extract obtained directly from SC leaf powder showed 72.6 ± 3.75% inhibitory activity while no inhibitory activity was observed with hexane fraction ([Table 1](#t0001){ref-type="table"}). Significantly higher inhibitory effects (*p* \< 0.0005) on amylase were recovered from methanol and water extracts of SC leaves compared to that of ethyl acetate extract according to the effects observed with 200 μg/mL extracts ([Table 1](#t0001){ref-type="table"}). Preliminary attempts to obtain active substances from methanol and water was not successful due to the very complex nature of these extracts, and the purification of these extracts remains as the subject of further study. Thus, in the present study the ethyl acetate extract obtained directly from SC leaf powder was subjected to bioassay-guided fractionation. The fraction eluted between 5 and 15% methanol to dichloromethane at the final step of silica gel column chromatography was found to be active against α-amylase, showing 97% inhibition at 200 μg/mL ([Table 1](#t0001){ref-type="table"}). TLC analysis of the fraction indicated that the fraction consists of UV-absorbing and UV-non absorbing compounds ([Figure 1(A)](#F0001){ref-type="fig"}). The mixture was successfully separated by PTLC developed with 3% methanol:chloroform in a TLC chamber saturated with NH~3~ ([Figure 1(B)](#F0001){ref-type="fig"}) and the UV-nonabsorbing compound was isolated. Isolated fraction showed a single peak with HPLC. The pure fraction isolated showed 99.6% inhibition on α-amylase at 100 μg. Inhibition % demonstrated with different concentrations (20--100 μg/mL) of pure fraction on amylase are shown in [Table 2](#t0002){ref-type="table"}. There was a significant enhancement of the inhibitory effects on amylase with the progress of purification (*p* \< 0.0005) with a decrease in IC~50~ from 704 to 39.9 μg/mL ([Table 1](#t0001){ref-type="table"}). The bioassay-guided fractionation of the ethyl acetate extract indicated that the UV-nonabsorbing pure fraction was responsible for the α-amylase inhibitory activity. In addition to the expected inhibition on amylase, pure fraction has also showed a strong inhibition on α-glucosidase with an IC~50~ of 28.2 μg/mL. Inhibition % demonstrated with different concentrations of pure fraction (10--60 mg/mL) on α-glucosidase are shown in [Table 2](#t0002){ref-type="table"} and the inhibition demonstrated was significantly higher than the inhibitory effects on α-amylase (*p* \< 0.01). These findings suggest two modes for the possible hypoglycaemic effects of the pure fraction isolated from SC leaves.

![TLC of the active fractions before and after final purification. (A) Prior to the final purification, (B) After the final purification with PTLC Solvent mixture: 5% MeOH: Chloroform.](IPHB_A_1257031_F0001_C){#F0001}

![Structures of Oleanolic acid (OA) and Ursolic acid (UA).](IPHB_A_1257031_F0002_B){#F0002}

###### 

Porcine pancreatic α-amylase inhibitory activity of SC fractions.

  Fraction                                        \% inhibition (Mean ± SD)                           Final concentration (μg/mL)   IC~50~ (μg/mL)
  ----------------------------------------------- --------------------------------------------------- ----------------------------- ----------------
  Hexane                                          Not detected                                        1000                           
  Ethyl acetate[^a^](#TF1){ref-type="table-fn"}   72.6 ± 3.8                                          1000                          704
                                                  10.9 ± 1.9[^\*\*\*\*^](#TF2){ref-type="table-fn"}   200                            
  Methanol                                        98.3 ± 2.3                                          1000                          61
                                                  71.1 ± 1.8[^\*\*\*\*^](#TF2){ref-type="table-fn"}   200                            
  Water                                           98.6 ± 1.6                                          1000                          48.3
                                                  81.4 ± 1.1[^\*\*\*\*^](#TF2){ref-type="table-fn"}   200                            
  Fraction eluted with 5--15% MeOH-CH~2~Cl~2~     97.4 ± 2.1[^\*\*\*\*^](#TF2){ref-type="table-fn"}   200                            
  Pure fraction                                   99.6 ± 0.5                                          100                           39.9
  Ursolic acid                                    97.5 ± 1.2[^\*\*\*\*^](#TF2){ref-type="table-fn"}   50                            6.9
  Oleanolic acid                                  37.5 ± 0.9[^\*\*\*\*^](#TF2){ref-type="table-fn"}   50                            57.4

Extracted with ethyl acetate directly from leaf powder.

*p* \< 0.0005 \[compared the fractions with equal concentrations (200 or 50 μg/mL)\].

###### 

Percentage inhibition of α-amylase and α-glucosidase by pure fraction.

  Final concentration (μg/mL)   \% Inhibition of α-amylase (Mean ± SD)   \% Inhibition of α-glucosidase (Mean ± SD)
  ----------------------------- ---------------------------------------- ---------------------------------------------------
  100                           99.6 ± 0.5                                
  80                            95.5 ± 1.6                                
  60                            78.9 ± 2.1                               87.1 ± 1.4[\*\*\*](#TF4){ref-type="table-fn"}
  50                            62.7 ± 0.8                               74.3 ± 1.5[^\*\*\*\*^](#TF5){ref-type="table-fn"}
  40                            37.8 ± 2.8                               64.0 ± 2.8[^\*\*\*\*^](#TF5){ref-type="table-fn"}
  30                            26.8 ± 1.5                               46.8 ± 1.9[^\*\*\*\*^](#TF5){ref-type="table-fn"}
  20                            20.5 ± 1.4                               29.3 ± 2.7[\*\*](#TF3){ref-type="table-fn"}
  10                                                                     13.4 ± 2.0

*p* \< 0.01.

*p* \< 0.005.

*p* \< 0.0005.

Active compound was identified by detailed analysis of ^1^H NMR and ^13^C NMR spectroscopic data and the direct comparison with TLC. The ^1^H NMR spectrum (recorded in CDCl~3~ containing a drop of CD~3~OD) of the active fraction showed signals of an oxymethine proton at *δ* 3.21 (dd, *J* = 10.9, 4.7 Hz) assignable to 3-proton of typical pentacyclic triterpenes and olefinic protons at *δ* 5.25 and 5.28 (brt each, *J* = 3.0 Hz) in a ratio of 3:1, characteristic of H-12 of ursolic acid and oleanolic acid, respectively. In addition, proton signals assignable to H-18 of ursolic acid and oleanolic acid were discerned at *δ* 2.19 (d, *J* = 11.4 Hz) *δ* 2.83 (dd, *J* = 13.2, 3.6 Hz) in a 3:1 ratio (Gohari et al. [@CIT0012]; Kolak et al. [@CIT0019]). The ^13^C NMR spectrum exhibited signals for an oxymethine carbon at *δ* 78.9 assignable to C-3 of pentacyclic triterpenes, olefinic carbons at 125.6 and 138.1, and C-28 carboxyl carbon at δ 170.5 for ursolic acid (Gohari et al. [@CIT0012]; Kolak et al. [@CIT0019]). TLC comparison (solvent: hexane:ethyl acetate 2:1) of the sample with authentic ursolic acid and oleanolic acid indicated the identity of the material. Finally, the sample was analyzed by reversed-phase HPLC in comparison with authentic acids (column, GL Sciences Inc. Inertsil ODS-3 (4.6 mm (i.d.) × 150 mm); solvent, methanol:water 10:1 containing 0.1% trifluoroacetic acid; flow rate 0.5 mL/min; detected at 215 nm). The sample exhibited two peaks at 16.5 and 17.2 min in a 3:1 ratio, which corresponded to the retention times of authentic ursolic acid (UA) and oleanolic acid (OA), respectively. Structures of UA and OA are shown in [Figure 2](#F0002){ref-type="fig"}. According to up to date literature, there has been no previous reports on identification of amylase inhibitors from SC leaf. When the activity of commercially available UA and hydrated form of OA was investigated, UA showed significantly higher inhibitory effects on both α-amylase and α-glucosidase compared to that of OA (*p* \< 0.0005). UA and OA showed IC~50~ of 6.7 and 57.4 μg/mL, respectively, against α-amylase and 3.1 and 44.1 μg/mL respectively, against α-glucosidase. Inhibition % with different concentrations of UA (2--50 μg/mL) and OA (20--80 μg/mL) on α-amylase and α-glucosidase are shown in [Tables 3](#t0003){ref-type="table"} and [4](#t0004){ref-type="table"}, respectively. Inhibitory effects of UA and OA on amylase and glucosidase isolated from various other sources have been shown previously although the IC~50~ values were varying from report to report (Komaki et al. [@CIT0020]; Ali et al. [@CIT0003]; Tiwari et al. [@CIT0043]).

###### 

Percentage inhibition of α-amylase and α-glucosidase by ursolic acid.

  Final concentration (μg/mL)   \% Inhibition of α-amylase (Mean ± SD)   \% Inhibition of α-glucosidase (Mean ± SD)
  ----------------------------- ---------------------------------------- ---------------------------------------------------
  02                            29.5 ± 1.0                               43.6 ± 1.0[^\*\*\*\*^](#TF8){ref-type="table-fn"}
  10                            47.3 ± 1.2                               66.7 ± 1.8[^\*\*\*\*^](#TF8){ref-type="table-fn"}
  20                            70.5 ± 2.0                               86.9 ± 2.2[\*\*\*](#TF7){ref-type="table-fn"}
  32                            88.4 ± 1.5                               94.5 ± 0.9[\*\*](#TF6){ref-type="table-fn"}
  50                            97.5 ± 1.2                                

*p* \< 0.01.

*p* \< 0.001.

*p* \< 0.0005.

###### 

Percentage inhibition of α-amylase and α-glucosidase by oleanolic acid.

  Final concentration (μg/mL)   \% Inhibition of α-amylase (Mean ± SD)   \% Inhibition of α-glucosidase (Mean ± SD)
  ----------------------------- ---------------------------------------- ----------------------------------------------------
  20                                                                     30.8 ± 1.7
  32                            31.4 ± 1.3                               35.5 ± 2.4^ns^
  50                            37.5 ± 0.9                               48.3 ± 0.5[^\*\*\*\*^](#TF13){ref-type="table-fn"}
  64                            54.1 ± 2.2                               59.8 ± 1.0[\*](#TF11){ref-type="table-fn"}
  80                            66.3 ± 1.4                               75.0 ± 0.7[\*\*](#TF12){ref-type="table-fn"}

: Not significant (*p* \> 0.05).

*p* \< 0.05.

*p* \< 0.005.

*p* \< 0.0005.

Discussion {#s0013}
==========

Bark, fruits, seeds and leaves of *S. cumini* are frequently used to treat diabetes in many parts of the world including Sri Lanka for centuries (Schoenfelder et al. [@CIT0036]; Ediriweera & Ratnasooriya [@CIT0009]). However, scientific data are lacking on the antidiabetic effects of SC leaves. Therefore, SC leaf extracts were investigated for α-amylase inhibitory effects and bioassay-guided fractionation was carried out in search of α-amylase inhibitors. Fractionation of the ethyl acetate extract afforded a UV-nonabsorbing fraction with a strong α-amylase inhibitory activity (IC~50~ 39.9 μg/mL). Even though the current study was not aimed to identify α-glucosidase inhibitors, the isolated fraction showed a strong inhibition on α-glucosidase too with an IC~50~ of 28.2 μg/mL. The active fraction was determined to be a 3:1 mixture of ursolic acid (UA) and oleanolic acid (OA).

Several studies have revealed the antidiabetic effects of SC bark and seeds in streptozotocin or alloxan induced diabetic rats. SC bark was shown to improve the oral glucose tolerance, elevate plasma insulin and stimulate pancreatic β-cell regeneration when an aqueous extract was given (Schossler et al. [@CIT0037]; Saravanan & Leelavinothan [@CIT0034]; Saravanan & Pari [@CIT0035]). Oral administration of ethyl acetate and methanol extracts of SC seeds has reduced blood glucose concentration in diabetic rats (Kumar et al. [@CIT0021]). SC seed extract also has shown inhibitory effects against α-amylase (Karthic et al. [@CIT0018]) and α-glucosidase (Shinde et al. [@CIT0039]).

There are contradictory findings with regard to the effectiveness of SC leaves as an antidiabetic agent. Essential oil from SC leaves inhibited α-amylase *in vitro* (Nishandhini et al. [@CIT0026]). Chloroform extract was also found to inhibit α-amylase *in vitro* while no inhibition was revealed with methanol and water extracts (Bhat et al. [@CIT0005]). In contrast to this observation, α-amylase inhibitory activities detected in methanol and water extracts in the present study were significantly high (*p* \< 0.0005). Findings of some other investigations too suggest antidiabetic effects of methanol, ethanol and water extracts. When the extracts of SC leaves, root, seeds and bark were administered to alloxan-induced diabetic rats the maximum antidiabetic efficacies were observed with methanol and aqueous extracts of leaves (Deb et al. [@CIT0008]). Ethanol extract of SC leaves was found to cause a decrease in the blood glucose, triglycerides and cholesterol concentrations when given to alloxan-induced diabetic rats (Schoenfelder et al. [@CIT0036]). In another study, ethanol extract of SC leaves exhibited α-glucosidase inhibitory activity with an IC~50~ of 17.4 μg/mL (Saraswaty [@CIT0033]). However, some investigations did not reveal antidiabetic effects of SC leaves. For instance, no antihyperglycaemic effects were observed upon administration of tea prepared from SC leaves to streptozotocin-induced diabetic rats for 2 weeks (Teixeira et al. [@CIT0042]) and to patients with type 2 diabetes for 4 weeks (Teixeira et al. [@CIT0041]). Similar negative outcome was reported when butanol fraction of leaves was given to diabetic mice (Oliveira et al. [@CIT0028]).

UA and OA are two isomeric pentacyclic triterpenoids, which are found in plants (Xu et al. [@CIT0045]). Triterpenoids are reported to be endowed with many pharmacological effects including antidiabetic effects (Castellano et al. [@CIT0007]). Multiple beneficial actions of UA and OA against diabetes are documented. These effects include preservation of pancreatic β-cells, improvement of insulin response (Castellano et al. [@CIT0007]), decrease in glucose 6-phosphatase activity, increase in glucokinase activity, glucose transporter 2 mRNA levels and liver glycogen (Lee et al. [@CIT0024]), stimulation of glucose uptake (He et al. [@CIT0014]), normalization of polyol pathway (Lee et al. [@CIT0024]) and superoxide anion scavenging activity, chelating effect, reducing power and inhibitory effects on glycation (Yin & Chan [@CIT0046]). Therapeutic effectiveness with no apparent side effects also has been reported with OA (Castellano et al. [@CIT0007]).

According to up to date literature, only one study has previously reported the identification of amylase inhibitors from SC. Betulinic acid and 3,5,7,4′-tetrahydroxyflavanone isolated from aqueous extract of SC seeds were found to be strong inhibitors of α-amylase (Karthic et al. [@CIT0018]). Even though UA was previously isolated from chloroform extract (Boonruad & Chansuwanich [@CIT0006]) and dichloromethane extracts (Ragasa et al. [@CIT0030]) of SC leaves its antidiabetic effects have not been reported. One study has documented identification of an α-glucosidase inhibitor (a flavonoid apigenin 7-*O*-glucoside) from SC seeds (Alagesan et al. [@CIT0002]).

The present study revealed the inhibitory activities of UA and OA isolated from SC leaves on α-amylase and α-glucosidase. A 2:1 mixture of OA and UA isolated from the hexane extract of *Phyllanthus amarus* Schum & Th. has exhibited a potent amylase inhibitory activity with IC~50~ of 2 μg/mL (Ali et al. [@CIT0003]). In another study, OA was found to inhibit α-amylase with an IC~50~ of 100 μg/mL (Komaki et al. [@CIT0020]). OA has been isolated from chloroform fraction of *Allium sativum* L. leaves (IC~50~ 83.6 μg/mL) (Meshram & Khamkar [@CIT0025]). OA and UA isolated from the dichloromethane and methanol extracts of *Callistemon lanceolatus* (Sm.) at 50 μg/kg also showed α-amylase inhibition (62.5 and 55.0%, respectively) (Kumar et al. [@CIT0022]). Furthermore, α-glucosidase inhibitory effects were found in OA isolated from fruits of *Sonneratia caseolaris* L. (IC~50~ 15.0 μM) (Tiwari et al. [@CIT0043]), OA and UA isolated from the dichloromethane and methanol extracts of *Callistemon lanceolatus* (84.2, 68.0%, respectively) at 50 μg/kg (Kumar et al. [@CIT0022]), UA and OA isolated from ethyl acetate extract of *Osmanthus fragrans* Lour. (IC~50~ 3.4 and 3.3 μg/mL, respectively) (Kang et al. [@CIT0017]) and UA and OA isolated from flowers of *Punica granatum* L. (IC~50~ 39.0 and 35.0 μM, respectively) (Salah El Dine et al. [@CIT0031]). In the present study UA and OA were recovered together during purification. It is reported that the separation of UA and OA is difficult as their chromatographic properties are very similar (Xu et al. [@CIT0045]).

Findings of the present study provide evidence for the effects of SC leaves in bringing down postprandial blood glucose concentrations. Reported antidiabetic effects of UA and OA isolated from other plants (Yin & Chan [@CIT0046]; Castellano et al. [@CIT0007]; He et al. [@CIT0014]; Lee et al. [@CIT0024]) suggest that there may be number of other antidiabetic effects too in UA and OA isolated from SC.

Conclusions {#s0014}
===========

This study demonstrated strong α-amylase inhibitory effects in ethyl acetate, methanol and water fractions of SC leaves. Two α-amylase inhibitors were identified through bioassay-guided fractionation of the ethyl acetate fraction. Final active fraction exhibited a porcine α-amylase inhibitory activity with an IC~50~ of 39.9 μg/mL and the content of the fraction was determined as a mixture of UA and OA (3:1) in a detail NMR analysis. The present study reports strong α-amylase and α-glucosidase inhibitory effects of UA and OA isolated from the SC leaves and validates the use of SC leaves in antidiabetic therapy. Furthermore, this study suggested the presence of other active compounds in the methanol and water fractions. As the fact indicates SC leaves are plausible for diabetic treatment, further studies to determine active compounds from methanol and water fractions are in progress.
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